MapLight Therapeutics, Inc.(MPLT),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

MPLT MapLight Therapeutics, Inc.

Market Closed 09-25 16:00:00 EDT

10.46

-0.30

-2.79%

盘后10.46

+0.000.00%

19:30 EDT

High10.87	Low10.39	Vol317.50K
Open10.81	D1 Closing10.76	Amplitude4.46%
Mkt Cap485.11M	Tradable Cap140.19M	Total Shares46.38M
T/O3.35M	T/O Rate2.37%	Tradable Shares13.40M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"MPLT","market":"US","secType":"STK","nameCN":"MapLight Therapeutics, Inc.","latestPrice":10.46,"timestamp":1790366400000,"preClose":10.76,"halted":0,"volume":317495,"hourTrading":{"tag":"盘后","latestPrice":10.46,"preClose":10.46,"latestTime":"19:30 EDT","volume":4780,"amount":49998.8,"timestamp":1790379004816,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":-0.02788104089219321,"floatShares":13402700,"shares":46377800,"eps":-5.058,"marketStatus":"Market Closed","change":-0.3,"latestTime":"09-25 16:00:00 EDT","open":10.81,"high":10.87,"low":10.39,"amount":3352782.4419449996,"amplitude":0.04461,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-5.058,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1790582400000},"marketStatusCode":7,"adr":0,"listingDate":1761537600000,"exchange":"NASDAQ","adjPreClose":10.76,"preHourTrading":{"tag":"盘前","latestPrice":10.91,"preClose":10.76,"latestTime":"09:17 EDT","volume":1252,"amount":13914.67792,"timestamp":1790342222142,"change":0.15,"changeRate":0.013941,"amplitude":0.036245},"postHourTrading":{"tag":"盘后","latestPrice":10.46,"preClose":10.46,"latestTime":"19:30 EDT","volume":4780,"amount":49998.8,"timestamp":1790379004816,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.4326958590058027,"impliedVol":0.7204,"impliedVolPercentile":0.0723},"requestUrl":"/m/hq/s/MPLT/wiki","defaultTab":"wiki","newsList":[{"id":"2670349247","title":"MapLight Therapeutics on Track for Record Losing Streak","url":"https://stock-news.laohu8.com/highlight/detail?id=2670349247","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670349247?lang=en_us&edition=fundamental","pubTime":"2026-09-25 00:56","pubTimestamp":1790268960,"startTime":"0","endTime":"0","summary":"MapLight Therapeutics, Inc.  is currently at $10.64, down $0.13 or 1.16%--Would be lowest close since July 27, 2026, when it closed at $9.90--On pace for largest percent decrease since Sept. 18, 2026, when it fell 3.53%--Currently down nine of the past 10 days--Currently down eight consecutive days; down 19.05% over this period--Longest losing streak on record --Worst eight-day stretch since the eight days ending Aug. 5, 2026, when it fell 64.66%--Down 17.93% month-to-date; on pace for worst month since July 2026, when it fell 63.67%--Down 39.4% year-to-date--Down 73.25% from its all-time closing high of $39.80 on July 9, 2026--Down 73.25% from its 52-week closing high of $39.80 on July 9, 2026--Up 7.47% from its 52-week closing low of $9.91 on July 27, 2026--Traded as low as $10.16--Down 5.66% at today's intraday lowAll data as of 12:53:47 PM ETSource: Dow Jones Market Data, FactSet","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","MPLT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668497338","title":"Maplight Therapeutics General Counsel Kristopher Hanson Sells 16,509 Shares for $192,654.03","url":"https://stock-news.laohu8.com/highlight/detail?id=2668497338","media":"Reuters","labels":["insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668497338?lang=en_us&edition=fundamental","pubTime":"2026-09-19 04:15","pubTimestamp":1789762544,"startTime":"0","endTime":"0","summary":"Maplight Therapeutics General Counsel Kristopher Hanson sells 16,509 shares for $192,654.03Maplight Therapeutics General Counsel Kristopher Hanson sold 16,509 voting common shares on Sept. 16, 2026 at","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260918:nNDL1zPZyd:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Maplight Therapeutics General Counsel Kristopher Hanson Sells 16,509 Shares for $192,654.03","news_tag":"insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","MPLT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666055890","title":"MapLight Therapeutics files to sell 13.18M shares of common stock for holders","url":"https://stock-news.laohu8.com/highlight/detail?id=2666055890","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666055890?lang=en_us&edition=fundamental","pubTime":"2026-09-10 05:30","pubTimestamp":1788989410,"startTime":"0","endTime":"0","summary":"This filing relates to the offer and sale from time to time by the selling stockholders of up to 13.18M shares of common stock. The company is not ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/maplight-therapeutics-files-to-sell-13-18m-shares-of-common-stock-for-holders-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/maplight-therapeutics-files-to-sell-13-18m-shares-of-common-stock-for-holders-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MPLT","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666558653","title":"Maplight Therapeutics - Prospectus Covers Resale of up to 13,181,055 Common Shares by Selling Stockholders - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2666558653","media":"THOMSON REUTERS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666558653?lang=en_us&edition=fundamental","pubTime":"2026-09-10 05:29","pubTimestamp":1788989380,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260909:nFWN45116O:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","MPLT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666873665","title":"MapLight Therapeutics to Present at Morgan Stanley Global Healthcare Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2666873665","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666873665?lang=en_us&edition=fundamental","pubTime":"2026-09-09 19:02","pubTimestamp":1788951775,"startTime":"0","endTime":"0","summary":"MapLight Therapeutics to present at Morgan Stanley Global Healthcare ConferenceMapLight Therapeutics management will present at Morgan Stanley’s 24th Annual Global Healthcare Conference in New York on","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260909:nNDLPGlTB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BN0W2W23.USD","IE00BQXX3C00.GBP","SG9999014013.SGD","IE00BQXX3D17.EUR","IE00BN0W2T93.GBP","IE00B3QW5Z07.USD","LU2095319765.USD","IE00BQXX3F31.USD","BK4585","IE00B64PRP62.GBP","SG9999014005.SGD","LU2210149790.SGD","NDAQ","BK4112","LU0314104364.USD","MPLT","IE00BKPKM429.USD","BK4588","IE00BGHQF748.EUR","SG9999014039.USD","IE00BN0W2V16.EUR","SG9999014021.USD","BCDF","LU2210150020.SGD","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663229077","title":"MapLight Therapeutics price target lowered to $43 from $45 at Needham","url":"https://stock-news.laohu8.com/highlight/detail?id=2663229077","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663229077?lang=en_us&edition=fundamental","pubTime":"2026-08-31 19:15","pubTimestamp":1788174932,"startTime":"0","endTime":"0","summary":"Needham lowered the firm’s price target on MapLight Therapeutics (MPLT) to $43 from $45 and keeps a Buy rating on the shares. The firm is updating ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/maplight-therapeutics-price-target-lowered-to-43-from-45-at-needham-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/maplight-therapeutics-price-target-lowered-to-43-from-45-at-needham-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MPLT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660490191","title":"Catalyst4 Acquires $50.07 Million of MapLight Therapeutics Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2660490191","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660490191?lang=en_us&edition=fundamental","pubTime":"2026-08-19 06:56","pubTimestamp":1787093780,"startTime":"0","endTime":"0","summary":"Catalyst4 acquires $50.07 million of MapLight Therapeutics common sharesCatalyst4 increased its Maplight Therapeutics stake with a purchase of 4.4 million voting common shares at USD 11.38 each.Benefi","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260818:nNDLbk2NP0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Catalyst4 Acquires $50.07 Million of MapLight Therapeutics Common Shares","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","MPLT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660248003","title":"Morgan Stanley Keeps Their Hold Rating on MapLight Therapeutics, Inc. (MPLT)","url":"https://stock-news.laohu8.com/highlight/detail?id=2660248003","media":"TIPRANKS","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660248003?lang=en_us&edition=fundamental","pubTime":"2026-08-17 20:57","pubTimestamp":1786971453,"startTime":"0","endTime":"0","summary":"In a report released today, Sean Laaman from Morgan Stanley maintained a Hold rating on MapLight Therapeutics, Inc., with a price target of $21.00....","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/morgan-stanley-keeps-their-hold-rating-on-maplight-therapeutics-inc-mplt-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate","earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/morgan-stanley-keeps-their-hold-rating-on-maplight-therapeutics-inc-mplt-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MPLT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659074172","title":"MapLight Therapeutics price target lowered to $21 from $24 at Canaccord","url":"https://stock-news.laohu8.com/highlight/detail?id=2659074172","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659074172?lang=en_us&edition=fundamental","pubTime":"2026-08-16 21:18","pubTimestamp":1786886308,"startTime":"0","endTime":"0","summary":"Canaccord analyst Sumant Kulkarni lowered the firm’s price target on MapLight Therapeutics (MPLT) to $21 from $24 and keeps a Buy rating on the sha...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/maplight-therapeutics-price-target-lowered-to-21-from-24-at-canaccord-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/maplight-therapeutics-price-target-lowered-to-21-from-24-at-canaccord-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MPLT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659140382","title":"Analysts’ Top NA Picks: Solv Energy (MWH), MapLight Therapeutics, Inc. (MPLT)","url":"https://stock-news.laohu8.com/highlight/detail?id=2659140382","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659140382?lang=en_us&edition=fundamental","pubTime":"2026-08-14 22:40","pubTimestamp":1786718411,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the NA sector as 2 analysts just weighed in on Solv Energy (MWH) and MapLight Therapeutics, Inc. (MPLT) wit...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-top-na-picks-solv-energy-mwh-maplight-therapeutics-inc-mplt-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-top-na-picks-solv-energy-mwh-maplight-therapeutics-inc-mplt-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["NA","BK4129","MWH","BK4141","BK4139","MPLT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659616715","title":"MapLight Therapeutics Q2 EPS $(1.32) Beats $(1.35) Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2659616715","media":"Benzinga Earnings","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659616715?lang=en_us&edition=fundamental","pubTime":"2026-08-14 04:27","pubTimestamp":1786652832,"startTime":"0","endTime":"0","summary":"MapLight Therapeutics Q2 EPS $(1.32) Beats $(1.35) Estimate","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/quote/MPLT","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"MapLight Therapeutics Q2 EPS $(1.32) Beats $(1.35) Estimate","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MPLT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659162232","title":"MapLight Q2 FY26 Net Loss Widens to $60.19 Million; R&D Expenses Rise to $53.44 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2659162232","media":"Reuters","labels":["shareholding","dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659162232?lang=en_us&edition=fundamental","pubTime":"2026-08-14 04:11","pubTimestamp":1786651916,"startTime":"0","endTime":"0","summary":"MapLight Q2 FY26 net loss widens to $60.19 million; R&D expenses rise to $53.44 millionMapLight Therapeutics posted a Q2 net loss of $60.19 million, widening from $29.85 million a year earlier.R&D exp","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260813:nNDL64hVdL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"shareholding,dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999014039.USD","SG9999014021.USD","BK4112","BK4139","LU2095319765.USD","MPLT","NDAQ","BK4588","IE00B64PRP62.GBP","LU0314104364.USD","LU2210149790.SGD","SG9999014013.SGD","IE00BGHQF748.EUR","IE00BN0W2W23.USD","IE00BN0W2V16.EUR","LU2210150020.SGD","BK4585","IE00BKPKM429.USD","IE00B3QW5Z07.USD","SG9999014005.SGD","IE00BN0W2T93.GBP","BCDF"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659162663","title":"Press Release: MapLight Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2659162663","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659162663?lang=en_us&edition=fundamental","pubTime":"2026-08-14 04:05","pubTimestamp":1786651500,"startTime":"0","endTime":"0","summary":"trial of ML-007C-MA in adults with schizophrenia experiencing an acute. exacerbation of psychosis. The trial met its primary endpoint, with the. 210/3 mg twice-daily dose demonstrating a statistically significant and. clinically meaningful reduction in PANSS total score compared with. -- ML-007C-MA also demonstrated improvement on a prespecified. impairment and significant separation on key secondary endpoints,including CGI-S and the PANSS Marder positive factor.-- ML-007C-MA was generally well tolerated, with no serious or drug-related. severe adverse events and low rates of GI-related discontinuations. Its. clinical profile, including simple initiation, 99% of patients reaching","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1718418525.SGD","LU2168564222.USD","LU2417539215.USD","LU0942090050.USD","ASD","LU1989764748.USD","ADP","LATR","BK4613","LU2023250504.SGD","LU2462157665.USD","LU2360107671.USD","XLF","BK4585","LU0056508442.USD","LU2361044865.SGD","IYG","LU1236620750.USD","IE00B1XK9C88.USD","LU2764262908.HKD","IE00BYQQ9H92.USD","VFH","IE00BJJMRX11.SGD","FDFF","LU0353189763.USD","LU1623119135.USD","IE00BQXX3C00.GBP","LU0868494617.USD","LU0965509010.AUD","MA","FNCL","IE000WAW04H5.SGD","IPAY","LU0234570918.USD","MPLT","UYG","LU1145028129.USD","LU1316542783.SGD","LU2404859667.USD","LU0174119429.USD","LU0006306889.USD","LU2347655073.USD","IE00B775H168.HKD","LU0672654240.SGD","BK4559","STBQ","IE0005OL40V9.USD","LU0061474705.USD","IE000F7OJYX1.SGD","LU1084165304.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659157908","title":"MapLight Therapeutics Prices USD 150 Million PIPE at USD 11.38 a Share","url":"https://stock-news.laohu8.com/highlight/detail?id=2659157908","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659157908?lang=en_us&edition=fundamental","pubTime":"2026-08-13 21:10","pubTimestamp":1786626622,"startTime":"0","endTime":"0","summary":"MapLight Therapeutics prices USD 150 million PIPE at USD 11.38 a shareMapLight Therapeutics priced a USD 150 million PIPE of unregistered equity securities, led by new and existing institutional inves","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260813:nNDL3K2fQX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BCDF","BK4585","IE00B64PRP62.GBP","IE00BN0W2T93.GBP","IE00BN0W2W23.USD","IE00BKPKM429.USD","SG9999014005.SGD","SG9999014021.USD","BK4588","LU2210150020.SGD","BK4112","NDAQ","LU0314104364.USD","SG9999014013.SGD","SG9999014039.USD","IE00BGHQF748.EUR","MPLT","LU2210149790.SGD","IE00B3QW5Z07.USD","LU2095319765.USD","IE00BN0W2V16.EUR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659979157","title":"Maplight Therapeutics Announces $150 Million Private Placement Financing","url":"https://stock-news.laohu8.com/highlight/detail?id=2659979157","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659979157?lang=en_us&edition=fundamental","pubTime":"2026-08-13 21:10","pubTimestamp":1786626600,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260813:nTUA2BY2WN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["MPLT","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659157434","title":"MapLight Therapeutics Announces $150 Million Private Placement Financing","url":"https://stock-news.laohu8.com/highlight/detail?id=2659157434","media":"GlobeNewswire","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659157434?lang=en_us&edition=fundamental","pubTime":"2026-08-13 21:10","pubTimestamp":1786626600,"startTime":"0","endTime":"0","summary":"SAN FRANCISCO and BOSTON, Aug.  13, 2026 (GLOBE NEWSWIRE) -- MapLight Therapeutics, Inc. (Nasdaq: MPLT), a clinical-stage biopharmaceutical company focused on improving the lives of patients suffering","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/08/13/3344584/0/en/maplight-therapeutics-announces-150-million-private-placement-financing.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MPLT","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658956143","title":"MapLight Therapeutics Price Target Cut to $13.00/Share from $52.00 by UBS","url":"https://stock-news.laohu8.com/highlight/detail?id=2658956143","media":"Dow Jones","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658956143?lang=en_us&edition=fundamental","pubTime":"2026-08-11 04:00","pubTimestamp":1786392000,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/MPLT/analyst-ratings","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MPLT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658793933","title":"UBS Downgrades MapLight Therapeutics to Neutral From Buy, Adjusts PT to $13 From $52","url":"https://stock-news.laohu8.com/highlight/detail?id=2658793933","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658793933?lang=en_us&edition=fundamental","pubTime":"2026-08-10 19:43","pubTimestamp":1786362188,"startTime":"0","endTime":"0","summary":"MapLight Therapeutics (MPLT) has an average rating of Buy and mean price target of $32.31, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from maj","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["MPLT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657195595","title":"Maplight Therapeutics CSO Lillie James Woodruff Sells 22,082 Shares for $276,908.28","url":"https://stock-news.laohu8.com/highlight/detail?id=2657195595","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657195595?lang=en_us&edition=fundamental","pubTime":"2026-08-05 08:40","pubTimestamp":1785890431,"startTime":"0","endTime":"0","summary":"Maplight Therapeutics CSO Lillie James Woodruff sells 22,082 shares for $276,908.28Maplight Therapeutics Chief Scientific Officer Lillie James Woodruff sold 22,082 shares of voting common stock on Aug","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260805:nNDL2JY0R2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Maplight Therapeutics CSO Lillie James Woodruff Sells 22,082 Shares for $276,908.28","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MPLT","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655384282","title":"Catalyst4 Reports $13.84 Million MapLight Therapeutics Common Share Purchase","url":"https://stock-news.laohu8.com/highlight/detail?id=2655384282","media":"Reuters","labels":["shareholding","insiderTrades","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655384282?lang=en_us&edition=fundamental","pubTime":"2026-07-31 06:40","pubTimestamp":1785451206,"startTime":"0","endTime":"0","summary":"Catalyst4 reports $13.84 million MapLight Therapeutics common share purchaseCatalyst4, a 10% owner of Maplight Therapeutics, reported open-market purchases totaling 1,209,225 voting common shares.Purc","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260730:nNDLfqNPZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Catalyst4 Reports $13.84 Million MapLight Therapeutics Common Share Purchase","news_tag":"shareholding,insiderTrades,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MPLT","BK4139"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.maplightrx.com","stockEarnings":[{"period":"1week","weight":-0.0421},{"period":"1month","weight":-0.1866},{"period":"3month","weight":-0.6857},{"period":"6month","weight":-0.4361},{"period":"1year","weight":-0.3847},{"period":"ytd","weight":-0.4045}],"compareEarnings":[{"period":"1week","weight":0.0127},{"period":"1month","weight":0.0069},{"period":"3month","weight":0.0581},{"period":"6month","weight":0.2165},{"period":"1year","weight":0.1722},{"period":"ytd","weight":0.1311}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"exchange":"NASDAQ","name":"MapLight Therapeutics, Inc.","nameEN":"MapLight Therapeutics, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.50.1","shortVersion":"4.50.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"MapLight Therapeutics, Inc.(MPLT),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest MapLight Therapeutics, Inc.(MPLT) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"MapLight Therapeutics, Inc.,MPLT,MapLight Therapeutics, Inc.股票,MapLight Therapeutics, Inc.股票老虎,MapLight Therapeutics, Inc.股票老虎国际,MapLight Therapeutics, Inc.行情,MapLight Therapeutics, Inc.股票行情,MapLight Therapeutics, Inc.股价,MapLight Therapeutics, Inc.股市,MapLight Therapeutics, Inc.股票价格,MapLight Therapeutics, Inc.股票交易,MapLight Therapeutics, Inc.股票购买,MapLight Therapeutics, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"MapLight Therapeutics, Inc.(MPLT),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest MapLight Therapeutics, Inc.(MPLT) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction